Prognostic significance of ADAM17 expression in patients with gastric cancer who underwent curative gastrectomy

Aydin, D.; Bilici, A.; Yavuzer, D.; KEFELİ, UMUT; Tan, A.; Ercelep, O.; Mert, A.; Yuksel, S.; Ozcelik, M.; Isik, D.; Surmeli, H.; Odabasi, H.; ALİUSTAOĞLU, MEHMET

doi:10.1007/s12094-015-1283-1

Prognostic significance of ADAM17 expression in patients with gastric cancer who underwent curative gastrectomy

Atıf İçin Kopyala

Aydin D., Bilici A., Yavuzer D., KEFELİ U., Tan A., Ercelep O., ...Daha Fazla

CLINICAL & TRANSLATIONAL ONCOLOGY, cilt.17, sa.8, ss.604-611, 2015 (SCI İndekslerine Giren Dergi)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 17 Konu: 8
Basım Tarihi: 2015
Doi Numarası: 10.1007/s12094-015-1283-1
Dergi Adı: CLINICAL & TRANSLATIONAL ONCOLOGY
Sayfa Sayıları: ss.604-611

Özet

A disintegrin and metalloproteinase (ADAM) 17 has been indicated to be an indispensable regulator of cellular events from proliferation to migration. Although prognostic importance of ADAM17 expression has been investigated in several tumours, its clinical utility as a useful prognostic molecular marker remains unclear in gastric cancer. In the current study, we evaluated the expression of ADAM17 and its prognostic significance in gastric cancer patients after curative gastrectomy.